Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria

NCT03847090 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

92

Enrollment

INDUSTRY

Sponsor class

Stopped Interim Analysis -

Conditions

Enteric Hyperoxaluria

Interventions

DRUG: Reloxaliase
DRUG: Placebo

Sponsor

Allena Pharmaceuticals